Biotech, Cannabis, Food & Drug, & Pharma Law Updates

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotech, Cannabis, Food & Drug, & Pharma Administration News

Title
Publication Date Organization
Jan
17
2020
DOE Announces Funding For Bioenergy Crops Research Bergeson & Campbell, P.C.
Jan
17
2020
FSIS Publishes Updated Guidelines for “Non-GMO” Labeling Claims Keller and Heckman LLP
Jan
16
2020
Regulatory Agencies Launch Unified Website for Biotechnology Regulation Mintz
Jan
16
2020
Bipartisan Group of Representatives Introduces Bill that Would Give FDA Authority to Regulate CBD as a Dietary Supplement Keller and Heckman LLP
Jan
16
2020
US Office of Management and Budget Issues a Memorandum Calling for Agency Plans From Federal Government Agencies McDermott Will & Emery
Jan
16
2020
Forecast for U.S. Federal and International Chemical Regulatory Policy 2020 Bergeson & Campbell, P.C.
Jan
16
2020
New Jersey Court Orders Employer to Reimburse Worker for Medical Marijuana Expenses in Workers’ Compensation Case Jackson Lewis P.C.
Jan
15
2020
EPA Announces January 22, 2020, Webinar on Reducing Vertebrate Animal Testing Bergeson & Campbell, P.C.
Jan
15
2020
Modernizing FDA’s Data Strategy: Agency Announces March 27 Public Meeting, Requests Written Comments by End of April McDermott Will & Emery
Jan
15
2020
New Laws in 2019 Regulating Pharmacy Benefit Managers Polsinelli PC
Jan
15
2020
FDA Responds to Three Dietary Fiber Citizen Petitions Keller and Heckman LLP
Jan
15
2020
FDA’s New Enforcement Priority Guidance for E-Cigarettes Focuses on Flavored Cartridge-Based Devices as well as Companies and Products that FDA Views as Targeting Youth Keller and Heckman LLP
Jan
15
2020
New Joint Website on Agricultural Biotechnology Products Launched by EPA, USDA, and FDA Bergeson & Campbell, P.C.
Jan
14
2020
Pharmaceutical Company Agrees To $54 Million To Settle False Claims Kickback Allegations Tycko & Zavareei LLP
Jan
14
2020
Day 1 Notes at the 2020 J.P. Morgan Healthcare Conference Sheppard, Mullin, Richter & Hampton LLP
Jan
14
2020
FDA Warns Companies about Processing, Distributing and Marketing Unapproved Stem Cell Products Faegre Drinker
Jan
14
2020
FDA’s New Enforcement Priority Guidance for E-Cigarettes Focuses on Flavored Cartridge-Based Devices and Companies and Products that FDA Views as Targeting Kids Keller and Heckman LLP
Jan
13
2020
2020 Starts Off With Two Government Publications Critical Of 340B Program Oversight McDermott Will & Emery
Jan
13
2020
Eighth Circuit Strikes Down Multiple Missouri Alcohol Beverage Advertising Laws McDermott Will & Emery
Jan
13
2020
Release by FDA, USDA, and EPA of New Joint Website on Biotechnology Regulation Keller and Heckman LLP
Jan
13
2020
Cures Act Developments: FDA Publishes CFR Amendments Exempting Class II Devices with an Interesting Addition Mintz
Jan
10
2020
Pennsylvania Health Insurers Must Cover Medication Synchronization Services Beginning July 2020 Dinsmore & Shohl LLP
Jan
10
2020
A Simple Guide to Zantac Cancer Lawsuits and Settlements Stark & Stark
Jan
10
2020
California Finalizes the Listing of Cannabis (Marijuana) Smoke and Δ-9-Tetrahydrocannabinol as Reproductive Toxicants Under Proposition 65 Keller and Heckman LLP
Jan
10
2020
BRAG Biobased Products Blog: January 10, 2020 Bergeson & Campbell, P.C.
Jan
10
2020
Unpacking The Solicitor General’s Brief In Vanda Foley & Lardner LLP
Jan
9
2020
Teva Pharmaceuticals Settles to Pay Over $519 Million in Penalties for Violations of the Foreign Corrupt Practices Act Kohn, Kohn & Colapinto
Jan
9
2020
Mexican Chamber of Deputies Approves Bill that Prohibits Use of Dairy Terms on Plant-Based Alternatives Keller and Heckman LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins